Literature DB >> 11438450

Induction of c-Met proto-oncogene by Epstein-Barr virus latent membrane protein-1 and the correlation with cervical lymph node metastasis of nasopharyngeal carcinoma.

T Horikawa1, T S Sheen, H Takeshita, H Sato, M Furukawa, T Yoshizaki.   

Abstract

Nasopharyngeal carcinoma (NPC) is distinctive in head and neck carcinomas for its close association with Epstein-Barr virus and its highly metastatic nature. Up-regulation of cell motility is essential for enhancement of metastatic potential. The expression of c-Met proto-oncogene, a high-affinity receptor for hepatocyte growth factor/scatter factor, has been reported to correlate with metastatic ability of the tumor cell. We observed close association of c-Met expression with cervical lymph node metastasis (P = 0.0272) in 39 NPC specimens studied immunohistochemically. Epstein-Barr virus-encoding latent membrane protein-1 (LMP-1) is a primary oncogene and is suggested to enhance the metastatic property of NPC. Previously, we reported that LMP-1 enhanced the motility of Madin-Darby canine kidney (MDCK) epithelial cells that was mediated by activation of Ets-1 transcription factor. Therefore, we examined the interrelationships of LMP-1, Ets-1, and c-Met. In immunohistochemical studies, the expression of LMP-1, Ets-1, and c-Met correlated significantly with each other in NPC (LMP-1 versus Ets-1, P < 0.0001; Ets-1 versus c-Met, P = 0.0012; LMP-1 versus Met, P = 0.0005). Transfection of LMP-1-expressing plasmid in MDCK cells induced c-Met protein expression. The c-Met protein was also induced by Ets-1 expression, and induction of c-Met by LMP-1 was suppressed by introducing a dominant-negative form of Ets-1 in LMP-1-expressing MDCK cells. These results suggest that LMP-1 induces c-Met through the activation of Ets-1, which may contribute in part to the highly metastatic potential of NPC.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11438450      PMCID: PMC1850422          DOI: 10.1016/S0002-9440(10)61669-0

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  40 in total

1.  Matrix metalloproteinase 9 is induced by the Epstein-Barr virus BZLF1 transactivator.

Authors:  T Yoshizaki; H Sato; S Murono; J S Pagano; M Furukawa
Journal:  Clin Exp Metastasis       Date:  1999-07       Impact factor: 5.150

2.  EBV associated malignancies.

Authors:  N Raab-Traub; K Flynn; C Klein; G Pizza; C De Vinci; L Occhiuzzi; G Farneti; U Caliceti; E Pirodda
Journal:  J Exp Pathol       Date:  1987

3.  An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells.

Authors:  D Wang; D Liebowitz; E Kieff
Journal:  Cell       Date:  1985-12       Impact factor: 41.582

4.  Transformation of Madin-Darby canine kidney (MDCK) epithelial cells by Epstein-Barr virus latent membrane protein 1 (LMP1) induces expression of Ets1 and invasive growth.

Authors:  K R Kim; T Yoshizaki; H Miyamori; K Hasegawa; T Horikawa; M Furukawa; S Harada; M Seiki; H Sato
Journal:  Oncogene       Date:  2000-03-30       Impact factor: 9.867

5.  Overexpression of c-Met protein in human thyroid tumors correlated with lymph node metastasis and clinicopathologic stage.

Authors:  B K Chen; Y Ohtsuki; M Furihata; T Takeuchi; J Iwata; S B Liang; H Sonobe
Journal:  Pathol Res Pract       Date:  1999       Impact factor: 3.250

6.  Association of latent membrane protein 1 and matrix metalloproteinase 9 with metastasis in nasopharyngeal carcinoma.

Authors:  T Horikawa; T Yoshizaki; T S Sheen; S Y Lee; M Furukawa
Journal:  Cancer       Date:  2000-08-15       Impact factor: 6.860

7.  Expression of Epstein-Barr virus-encoded proteins in nasopharyngeal carcinoma.

Authors:  R Fåhraeus; H L Fu; I Ernberg; J Finke; M Rowe; G Klein; K Falk; E Nilsson; M Yadav; P Busson
Journal:  Int J Cancer       Date:  1988-09-15       Impact factor: 7.396

8.  Expression of c-Met and heparan-sulfate proteoglycan forms of CD44 in colorectal cancer.

Authors:  V J Wielenga; R van der Voort; T E Taher; L Smit; E A Beuling; C van Krimpen; M Spaargaren; S T Pals
Journal:  Am J Pathol       Date:  2000-11       Impact factor: 4.307

9.  Biological diversity in metastatic neoplasms: origins and implications.

Authors:  I J Fidler; I R Hart
Journal:  Science       Date:  1982-09-10       Impact factor: 47.728

10.  Epstein-Barr virus gene expression in nasopharyngeal carcinoma.

Authors:  L S Young; C W Dawson; D Clark; H Rupani; P Busson; T Tursz; A Johnson; A B Rickinson
Journal:  J Gen Virol       Date:  1988-05       Impact factor: 3.891

View more
  37 in total

1.  The Epstein-Barr virus oncogene product, latent membrane protein 1, induces the downregulation of E-cadherin gene expression via activation of DNA methyltransferases.

Authors:  Chi-Neu Tsai; Chia-Lung Tsai; Ka-Po Tse; Hwan-You Chang; Yu-Sun Chang
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-10       Impact factor: 11.205

2.  Inhibition of c-Met downregulates TIGAR expression and reduces NADPH production leading to cell death.

Authors:  V W Y Lui; E Y L Wong; K Ho; P K S Ng; C P Y Lau; S K W Tsui; C-M Tsang; S-W Tsao; S H Cheng; M H L Ng; Y K Ng; E K Y Lam; B Hong; K W Lo; T S K Mok; A T C Chan; G B Mills
Journal:  Oncogene       Date:  2010-11-08       Impact factor: 9.867

3.  Anti-invasion, anti-proliferation and anoikis-sensitization activities of lapatinib in nasopharyngeal carcinoma cells.

Authors:  Vivian Wai Yan Lui; Cecilia Pik Yuk Lau; Kakiu Ho; Margaret Heung Ling Ng; Suk Hang Cheng; Sai-Wah Tsao; Chi Man Tsang; Kenny Ieng Kit Lei; Anthony Tc Chan; Tony Shu Kam Mok
Journal:  Invest New Drugs       Date:  2010-06-23       Impact factor: 3.850

4.  Dysregulation of HER2/HER3 signaling axis in Epstein-Barr virus-infected breast carcinoma cells.

Authors:  Jiun-Han Lin; Ching-Hwa Tsai; Jan-Show Chu; Jeou-Yuan Chen; Kenzo Takada; Jin-Yuh Shew
Journal:  J Virol       Date:  2007-03-21       Impact factor: 5.103

5.  Targeting MET by tyrosine kinase inhibitor suppresses growth and invasion of nasopharyngeal carcinoma cell lines.

Authors:  Patrick C Lau; Elaine Y Wong
Journal:  Pathol Oncol Res       Date:  2011-08-25       Impact factor: 3.201

Review 6.  The role of Epstein-Barr virus infection in the pathogenesis of nasopharyngeal carcinoma.

Authors:  Chi Man Tsang; Sai Wah Tsao
Journal:  Virol Sin       Date:  2015-04-21       Impact factor: 4.327

7.  Epstein-Barr virus encoded latent membrane protein 1 regulates mTOR signaling pathway genes which predict poor prognosis of nasopharyngeal carcinoma.

Authors:  Jing Chen; Chun-Fang Hu; Jing-Hui Hou; Qiong Shao; Li-Xu Yan; Xiao-Feng Zhu; Yi-Xin Zeng; Jian-Yong Shao
Journal:  J Transl Med       Date:  2010-03-26       Impact factor: 5.531

8.  Interleukins, laminin and Epstein - Barr virus latent membrane protein 1 (EBV LMP1) promote metastatic phenotype in nasopharyngeal carcinoma.

Authors:  Michelle M S Chew; Sook-Yee Gan; Alan S B Khoo; Eng-Lai Tan
Journal:  BMC Cancer       Date:  2010-10-22       Impact factor: 4.430

Review 9.  Viral Carcinogenesis Beyond Malignant Transformation: EBV in the Progression of Human Cancers.

Authors:  Deilson Elgui de Oliveira; Bárbara G Müller-Coan; Joseph S Pagano
Journal:  Trends Microbiol       Date:  2016-04-07       Impact factor: 17.079

10.  Molecular events associated with epithelial to mesenchymal transition of nasopharyngeal carcinoma cells in the absence of Epstein-Barr virus genome.

Authors:  Jung-Chung Lin; Shuen-Kuei Liao; En-Huei Lee; Man-Shan Hung; Yiyang Sayion; Hung-Chang Chen; Chen-Chen Kang; Liang-Sheng Huang; Jaw-Ming Cherng
Journal:  J Biomed Sci       Date:  2009-11-24       Impact factor: 8.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.